DE69414947D1 - Dialyselösung zur extrakorporalen Hemodialyse - Google Patents

Dialyselösung zur extrakorporalen Hemodialyse

Info

Publication number
DE69414947D1
DE69414947D1 DE69414947T DE69414947T DE69414947D1 DE 69414947 D1 DE69414947 D1 DE 69414947D1 DE 69414947 T DE69414947 T DE 69414947T DE 69414947 T DE69414947 T DE 69414947T DE 69414947 D1 DE69414947 D1 DE 69414947D1
Authority
DE
Germany
Prior art keywords
dialysis solution
renal
composition
extracorporeal hemodialysis
nephrosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69414947T
Other languages
English (en)
Other versions
DE69414947T2 (de
Inventor
Kazumi Ogata
Takahiro Sakaue
Noriko Saito
Sachiko Matsuura
Rie Nagao
Shinya Ogino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Publication of DE69414947D1 publication Critical patent/DE69414947D1/de
Application granted granted Critical
Publication of DE69414947T2 publication Critical patent/DE69414947T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
DE69414947T 1993-09-10 1994-09-07 Dialyselösung zur extrakorporalen Hemodialyse Expired - Fee Related DE69414947T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22538993 1993-09-10

Publications (2)

Publication Number Publication Date
DE69414947D1 true DE69414947D1 (de) 1999-01-14
DE69414947T2 DE69414947T2 (de) 1999-07-08

Family

ID=16828600

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69414947T Expired - Fee Related DE69414947T2 (de) 1993-09-10 1994-09-07 Dialyselösung zur extrakorporalen Hemodialyse

Country Status (8)

Country Link
US (1) US5474992A (de)
EP (1) EP0643969B1 (de)
KR (1) KR950007845A (de)
AT (1) ATE173928T1 (de)
CA (1) CA2129509A1 (de)
DE (1) DE69414947T2 (de)
ES (1) ES2124348T3 (de)
TW (1) TW298566B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2244535A1 (en) * 1995-05-15 2000-01-30 Avon Products, Inc. Novel uses for ascorbyl-phosphoryl-cholesterol in topical compositions
US6162450A (en) * 1995-05-15 2000-12-19 Avon Products, Inc. Uses of ascorbyl-phosphoryl-cholesterol and compositions for practicing same
US6436969B1 (en) 1995-09-12 2002-08-20 Kansas University Medical Center Research Institute Inc. Dialysis solutions and methods
JPH09194375A (ja) * 1996-01-17 1997-07-29 Senju Pharmaceut Co Ltd 免疫抑制作用増強剤
US7670491B2 (en) * 1998-10-20 2010-03-02 Advanced Renal Technologies Buffered compositions for dialysis
US6610206B1 (en) 1998-10-20 2003-08-26 Advanced Renal Technologies Buffered compositions for dialysis
WO2000051987A2 (en) 1999-03-05 2000-09-08 Kansas University Medical Center Inhibitors of advanced, post-amadori glycosylation reactions
ATE422915T1 (de) * 1999-09-22 2009-03-15 Advanced Renal Technologies Anwendung eines dialysats mit hohem zitratgehalt
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
CA2453823C (en) 2001-07-27 2010-12-21 Vital Health Sciences Pty Ltd Dermal therapy using phosphate derivatives of electron transfer agents
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
SE0400523D0 (sv) 2004-03-01 2004-03-01 Gambro Lundia Ab A medical solution, a method for producing said medical solution and use thereof
JP4847437B2 (ja) 2004-03-03 2011-12-28 バイタル ヘルス サイエンシズ プロプライアタリー リミティド アルカロイド製剤
KR101037152B1 (ko) * 2004-04-23 2011-05-26 엘지전자 주식회사 세탁기의 제어 방법
SE0402507D0 (sv) 2004-10-14 2004-10-14 Gambro Lundia Ab Medicinsk lösning, förfarande för framställning och användning därav
RU2428973C2 (ru) * 2005-03-03 2011-09-20 Вайтал Хэлф Сайнсис Пти Лтд Составы, обладающие липидопонижающими свойствами
MX2007015949A (es) 2005-06-17 2008-03-07 Vital Health Sciences Pty Ltd Un vehiculo que comprende uno o mas derivados de fosfato de di- y/o mono-(agentes de transferencia de electrones) o complejos de los mismos.
AU2011213557B2 (en) 2010-02-05 2015-05-07 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
CA2794734C (en) 2010-03-30 2017-12-12 Phosphagenics Limited Transdermal delivery patch
EP2685992A4 (de) 2011-03-15 2014-09-10 Phosphagenics Ltd Aminochinoline als kinasehemmer
CA3007587C (en) 2015-12-09 2023-12-05 Phosphagenics Limited Pharmaceutical formulation
BR112019012946A2 (pt) 2016-12-21 2019-11-26 Avecho Biotechnology Ltd processo

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25859A (en) * 1988-01-11 1991-12-02 Takeda Chemical Industries Ltd Composition for treatment of ischemic disorder
DK0409999T3 (da) * 1989-02-02 1993-11-01 Senju Pharma Co Anvendelse af L-ascorbin-2-phosphat-syre eller et farmaceutisk acceptabelt salt deraf til fremstilling af en skylleopløsning til hindring af skader op intraokulart væv
JP2854631B2 (ja) * 1989-11-21 1999-02-03 千寿製薬株式会社 糖尿病合併症および老化によって引き起こされる疾患の予防・治療剤
DE69125011T2 (de) * 1991-12-04 1997-09-25 Bertin & Cie Verfahren und Vorrichtung zur optischen Ferndetektion eines sich in einem beobachteten Raumgebiet befindenden Gases

Also Published As

Publication number Publication date
EP0643969B1 (de) 1998-12-02
US5474992A (en) 1995-12-12
ES2124348T3 (es) 1999-02-01
KR950007845A (ko) 1995-04-15
TW298566B (de) 1997-02-21
ATE173928T1 (de) 1998-12-15
DE69414947T2 (de) 1999-07-08
CA2129509A1 (en) 1995-03-11
EP0643969A3 (de) 1996-03-13
EP0643969A2 (de) 1995-03-22

Similar Documents

Publication Publication Date Title
DE69414947T2 (de) Dialyselösung zur extrakorporalen Hemodialyse
BR0014179A (pt) Modernos derivados de ácido aminodicarboxìlico com propriedades farmacêuticas
TNSN01035A1 (fr) Derives d'ethers de pyrazole nouveaux, et compositions pharmaceutiques les contenant.
TNSN98036A1 (fr) Derives d'acide hexanoique nouveaux
BR9910122A (pt) Compostos amidina
HRP20050843A2 (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use of the same as medicaments, and medicament containing such compounds
DE69933208D1 (de) Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt
DE69024826T2 (de) Aza-Macrozyklen und Verfahren zu deren Herstellung
SI21169B (sl) Nova uporaba peptidnega razreda spojine za zdravljenje alodinije ali drugih razliäśnih vrst kroniäśne ali fantomske boleäśine
TNSN01124A1 (fr) Derives de 1,4-dihydropyridine nouveaux , servant d'antagonistes de la bradykinine, et compositions les contenant
DK1218039T3 (da) Anvendelse af dialysat med höjt citratindhold
YU11601A (sh) Derivati fenil jantina
BR0013065A (pt) Método e composto para tratar de uma doença associada com recrutamento e/ ou ativação aberrante de leucócitos
MA38315A1 (fr) Composés tétracycliques substitués par un hétérocycle et procédés pour les utiliser pour le traitement de maladies virales
HK1044276A1 (en) Antithrombotic use of glycine betaine
DE69427344T2 (de) Verabreichung von riluzol zur behandlung von neuro-aids
EE200000527A (et) Faktorit Xa pärssivad heterotsüklilised derivaadid
ATE187642T1 (de) Verwendund von norastemizol zur behandlung der allergischen rhinitis
SE8500996D0 (sv) Method of treatment
DE69924146D1 (de) Etherlysophospholipide zur behandlung von chronischen entzündlichen erkrankungen
ATE285773T1 (de) Pharmazeutische zusammensetzungen zur behandlung von neurologischen krankheiten
FR20904E (fr) Perfectionnements à la purification, à la clarification et à la stérilisation de l'eau
AR043003A1 (es) Compuestos (benzoimidazol-2-il) fenilaminas n-sustituidas, procedimiento para su preparacion, su uso como farmacos o como ayuda en diagnostico, y los medicamentos que las contienen
Oakley et al. The use of dialysis bath fluid as a vehicle for a drug with a narrow therapeutic index—Lithium chloride
Baloch et al. Nephritis and charcot-marie-tooth disease: an unusual association

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee